Healthcare -
Biotechnology - NASDAQ - US
$ 8.64
1.77 %
$ 49.8 M
Market Cap
-0.34
P/E
ATRA - COST OF REVENUE
Cost of Revenue ATRA - Atara Biotherapeutics, Inc.
8.89 M
LAST VALUE
-11.63%
2 YEAR CAGR
18.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR